Houston, Tx – Recent reports of Nipah virus (NiV) infections in West Bengal, India, have reignited global concern, prompting public health authorities to prioritize research into this high-mortality pathogen. In response,… Read More
First U.S. commercial agreement delivers next-generation technology for faster, more accurate diagnostics BURLINGTON, N.C. – Labcorp, a global leader of innovative and comprehensive laboratory services, announced that it is the… Read More
Allschwil, CH – Idorsia Ltd announces an exclusive license and supply agreement with EMS S.A., Brazil’s largest privately-owned pharmaceutical company, to bring QUVIVIQ™ (daridorexant) to patients across Latin America. This… Read More
UBC Medicine researchers have created a topical CRISPR-based therapy that could offer a lasting cure for a range of skin disorders. Gene-editing tools like CRISPR have unlocked new treatments for… Read More
Quadruplet regimen demonstrated significantly deeper and more durable responses, higher MRD negativity and improved progression-free survival versus a standard of care Approval marks the twelfth indication for DARZALEX FASPRO® and… Read More
